Physician profile
Daniel Trementozzi
NPI 1821060047
$2,456.63
in general payments reported to CMS, 2019-2025
31 companies · $512 in 2025
The $512 reported for 2025 was more than what 94% of Pediatrics providers received nationally (typical 2025 total: $96.93).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $269 · 2020: $236 · 2021: $207 · 2022: $337 · 2023: $477 · 2024: $418 · 2025: $512.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,407.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,406.79 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $623.83 | 2019-2025 | Rybelsus, Ozempic, Wegovy |
| Amgen INC. | $292.14 | 2019-2025 | Repatha, Otezla, Otezla |
| Otsuka America Pharmaceutical, INC. | $222.07 | 2023-2025 | Rexulti |
| Lilly USA, LLC | $129.68 | 2022-2023 | Trulicity, Mounjaro, Jardiance |
| Pfizer INC. | $107.66 | 2021-2025 | |
| Merck Sharp & Dohme LLC | $105.58 | 2021-2025 | Gardasil 9, Vaxelis, Vaxneuvance |
| Abbott Laboratories | $95.89 | 2025 | Freestyle Libre 3 |
| Glaxosmithkline, LLC. | $94.19 | 2020-2025 | Shingrix, Arexvy, Pediarix |
| Abbvie INC. | $84.90 | 2023-2025 | Vraylar |
| Cranial Technologies, INC | $78.70 | 2019-2021 | |
| Exact Sciences Corporation | $67.14 | 2024-2025 | Cologuard Collection Kit, The Cologuard Plus Collection Kit |
| Philips North America LLC | $51.84 | 2024-2025 | (Ck6) Holter, Extended Holter |
| Ironshore Pharmaceuticals INC. | $46.20 | 2019 | |
| Sobi, INC | $44.63 | 2020 | |
| Lundbeck LLC | $41.32 | 2024-2025 | Rexulti |
Show all 31 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Biohaven Pharmaceutical Holding Company LTD. | $39.44 | 2022 | |
| Esperion Therapeutics, INC. | $37.45 | 2023-2025 | Nexletol |
| Shire North American Group INC | $34.94 | 2019 | |
| Sanofi Pasteur INC. | $34.87 | 2020-2023 | |
| Astrazeneca Pharmaceuticals LP | $30.89 | 2019-2025 | Farxiga |
| Bayer Healthcare Pharmaceuticals INC. | $29.63 | 2023-2024 | |
| Biogen, INC. | $21.72 | 2019 | |
| Corium, LLC | $21.46 | 2023 | Azstarys |
| Takeda Pharmaceuticals U.S.A., INC. | $18.18 | 2025 | Trintellix |
| Ultragenyx Pharmaceutical INC. | $18.04 | 2022 | |
| Vanda Pharmaceuticals INC. | $15.92 | 2025 | Fanapt |
| Adlon Therapeutics L.P. | $15.45 | 2020 | |
| Neurelis, INC. | $15.16 | 2025 | Valtoco |
| Collegium Pharmaceutical, INC. | $14.84 | 2025 | Jornay Pm |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $11.77 | 2019 | |
| Medtronic Minimed, INC. | $11.10 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Daniel Trementozzi listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.